MDMA Plus Exposure Therapy for PTSD

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 13, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

PTSD

Interventions

DRUG

MDMA

Participants will receive MDMA HCl (100 mg, 84 mg MDMA) in combination with massed exposure therapy for PTSD.

Trial Locations (1)

RECRUITING

Emory Brain Health Center, Atlanta

All Listed Sponsors

lead

Emory University

OTHER